Key result
Percutaneous atrial septal defect closure is a standard, less invasive therapy for ostium secundum ASDs, requiring detailed anatomical assessment to select appropriate devices and prevent complications.
Highlights the current status, indications, and critical complications of transcatheter ASD closure in Japan after nearly 20 years of clinical application.
Answers are grounded in this paper and cite their sources.
Highlights need for meticulous imaging and complication vigilance; extends 20-year experience but leaves device selection open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mizuhiko Ishigaki (2023) conducted a review in Atrial Septal Defect (ASD). Transcatheter Device Closure was evaluated. Percutaneous atrial septal defect closure is a standard, less invasive therapy for ostium secundum ASDs, requiring detailed anatomical assessment to select appropriate devices and prevent complications.
Synapse has enriched 10 related papers. Consider them for comparative context: